These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 21808037)
1. Emergence of potent inhibitors of metastasis in lung cancer via syntheses based on migrastatin. Lecomte N; Njardarson JT; Nagorny P; Yang G; Downey R; Ouerfelli O; Moore MA; Danishefsky SJ Proc Natl Acad Sci U S A; 2011 Sep; 108(37):15074-8. PubMed ID: 21808037 [TBL] [Abstract][Full Text] [Related]
2. Diverted total synthesis leads to the generation of promising cell-migration inhibitors for treatment of tumor metastasis: in vivo and mechanistic studies on the migrastatin core ether analog. Oskarsson T; Nagorny P; Krauss IJ; Perez L; Mandal M; Yang G; Ouerfelli O; Xiao D; Moore MA; Massagué J; Danishefsky SJ J Am Chem Soc; 2010 Mar; 132(9):3224-8. PubMed ID: 20155906 [TBL] [Abstract][Full Text] [Related]
3. The Therapeutic Potential of Migrastatin-Core Analogs for the Treatment of Metastatic Cancer. Giralt E; Lo Re D Molecules; 2017 Feb; 22(2):. PubMed ID: 28208778 [TBL] [Abstract][Full Text] [Related]
4. Quantitative structure-activity studies on a series of migrastatin analogs as inhibitors of cancer cell metastasis. Santos RN; Guido RV; Oliva G; Dias LC; Andricopulo AD Med Chem; 2011 May; 7(3):155-64. PubMed ID: 21486209 [TBL] [Abstract][Full Text] [Related]
6. Synthetic analogues of migrastatin that inhibit mammary tumor metastasis in mice. Shan D; Chen L; Njardarson JT; Gaul C; Ma X; Danishefsky SJ; Huang XY Proc Natl Acad Sci U S A; 2005 Mar; 102(10):3772-6. PubMed ID: 15728385 [TBL] [Abstract][Full Text] [Related]
7. Migrastatin analogues inhibit canine mammary cancer cell migration and invasion. Majchrzak K; Lo Re D; Gajewska M; Bulkowska M; Homa A; Pawłowski K; Motyl T; Murphy PV; Król M PLoS One; 2013; 8(10):e76789. PubMed ID: 24116159 [TBL] [Abstract][Full Text] [Related]
8. Discovery of potent cell migration inhibitors through total synthesis: lessons from structure-activity studies of (+)-migrastatin. Njardarson JT; Gaul C; Shan D; Huang XY; Danishefsky SJ J Am Chem Soc; 2004 Feb; 126(4):1038-40. PubMed ID: 14746469 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of migrastatin and its macroketone analogue and in vivo FRAP analysis of the macroketone on E-cadherin dynamics. Lo Re D; Zhou Y; Nobis M; Anderson KI; Murphy PV Chembiochem; 2014 Jul; 15(10):1459-64. PubMed ID: 24919421 [TBL] [Abstract][Full Text] [Related]
10. Lactimidomycin, iso-migrastatin and related glutarimide-containing 12-membered macrolides are extremely potent inhibitors of cell migration. Ju J; Rajski SR; Lim SK; Seo JW; Peters NR; Hoffmann FM; Shen B J Am Chem Soc; 2009 Feb; 131(4):1370-1. PubMed ID: 19132897 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of new migrastatin and dorrigocin congeners unveils cell migration inhibitors with dramatically improved potency. Ju J; Rajski SR; Lim SK; Seo JW; Peters NR; Hoffmann FM; Shen B Bioorg Med Chem Lett; 2008 Nov; 18(22):5951-4. PubMed ID: 18684620 [TBL] [Abstract][Full Text] [Related]
12. The migrastatin family: discovery of potent cell migration inhibitors by chemical synthesis. Gaul C; Njardarson JT; Shan D; Dorn DC; Wu KD; Tong WP; Huang XY; Moore MA; Danishefsky SJ J Am Chem Soc; 2004 Sep; 126(36):11326-37. PubMed ID: 15355116 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of Migrastatin Analogues as Inhibitors of Tumour Cell Migration: Exploring Structural Change in and on the Macrocyclic Ring. Lo Re D; Zhou Y; Mucha J; Jones LF; Leahy L; Santocanale C; Krol M; Murphy PV Chemistry; 2015 Dec; 21(50):17993. PubMed ID: 26537992 [TBL] [Abstract][Full Text] [Related]
14. Thermolysis of isomigrastatin and its congeners via [3,3]-sigmatropic rearrangement: a new route to the synthesis of migrastatin and its analogues. Ju J; Lim SK; Jiang H; Seo JW; Her Y; Shen B Org Lett; 2006 Dec; 8(25):5865-8. PubMed ID: 17134292 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of novel migrastatin and dorrigocin A analogues from D-glucal. Anquetin G; Rawe SL; McMahon K; Murphy EP; Murphy PV Chemistry; 2008; 14(5):1592-600. PubMed ID: 18038383 [TBL] [Abstract][Full Text] [Related]
16. Migrastatin, a new inhibitor of tumor cell migration from Streptomyces sp. MK929-43F1. Taxonomy, fermentation, isolation and biological activities. Nakae K; Yoshimoto Y; Sawa T; Homma Y; Hamada M; Takeuchi T; Imoto M J Antibiot (Tokyo); 2000 Oct; 53(10):1130-6. PubMed ID: 11132958 [TBL] [Abstract][Full Text] [Related]
17. Synthetic macrolides that inhibit breast cancer cell migration in vitro. Metaferia BB; Chen L; Baker HL; Huang XY; Bewley CA J Am Chem Soc; 2007 Mar; 129(9):2434-5. PubMed ID: 17295491 [No Abstract] [Full Text] [Related]
18. Furan Oxidation Strategy for the Synthesis of the Macrolactone Analogue of Migrastatin. Airan Y; Prasad KR J Org Chem; 2019 Nov; 84(22):14974-14979. PubMed ID: 31615208 [TBL] [Abstract][Full Text] [Related]
19. Migrastatin, a novel 14-membered ring macrolide, inhibits anchorage-independent growth of human small cell lung carcinoma Ms-1 cells. Takemoto Y; Nakae K; Kawatani M; Takahashi Y; Naganawa H; Imoto M J Antibiot (Tokyo); 2001 Dec; 54(12):1104-7. PubMed ID: 11858668 [No Abstract] [Full Text] [Related]
20. The total synthesis of (+)-migrastatin. Gaul C; Njardarson JT; Danishefsky SJ J Am Chem Soc; 2003 May; 125(20):6042-3. PubMed ID: 12785819 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]